Too Much Information?

USA Today takes a look at the rapid uptake of chromosomal microarrays for prenatal testing, noting that while the approach can detect more genetic abnormalities than current methods like karyotyping, the significance of many of these variants is often unknown.

"Our capacity to test and our capacity to make sense of the results are not well-aligned," Rachel Grob, the author of a book on prenatal and neonatal genetic testing, tells the paper.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.